Jump to content

Serdar Bulun: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
m Anarchyte moved page User:Serdar Bulun/sandbox/Serdar Bulun, MD to Serdar Bulun without leaving a redirect: histmerge
m Reverted to revision 813398750 by KolbertBot (talk): Before reset from histmerge. (TW)
Line 1: Line 1:
{{Multiple issues|
{{Userspace draft|source=ArticleWizard|date=January 2016}}
{{BLP self-published|date=January 2016}}
{{COI|date=January 2016}}
{{external links|date=January 2016}}
{{Orphan|date=January 2016}}
}}


{{Infobox scientist
{{Infobox scientist
| name = Serdar Bulun
| name = Serdar Bulun
| image =
| image =
| alt = A picture of Dr. Serdar Bulun
| alt =
| caption =
| caption = <!--(not needed as image is straightforward portrait)-->
| birth_place = [[Malatya]], [[Turkey]]
| birth_place = [[Malatya]], [[Turkey]]
| residence = {{ublist |[[Chicago, Illinois]] |[[United States]]}}
| residence = {{ublist |[[Chicago, Illinois]] |[[United States]]}}
| fields = {{ublist |[[Obstetrics and Gynecology]] |[[Reproductive endocrinology and infertility|Reproductive Endocrinology and Infertility]]}}
| fields = {{ublist |[[Obstetrics and Gynecology]] |[[Reproductive endocrinology and infertility]]}}
| workplaces = {{ublist |[[Northwestern University]] |[https://www.nm.org/location/prentice-womens-hospital Prentice Women's Hospital of Northwestern Memorial Hospital]}}<br />
| workplaces = {{ublist |[[Northwestern University]] |[https://www.nm.org/location/prentice-womens-hospital Prentice Women's Hospital] | [[Northwestern Memorial Hospital]]}}
|website = http://www.feinberg.northwestern.edu/sites/obgyn/research/labs/bulun/index.html
|website = http://www.feinberg.northwestern.edu/sites/obgyn/research/labs/bulun/index.html
}}
}}


'''Serdar Bulun, MD''' is a gynecologist, with a special interest in the common gynecologic diseases, [[endometriosis]] and [[uterine fibroids]].<ref name="bulun 2009">{{cite journal | pmid = 19144942 | doi=10.1056/NEJMra0804690 | volume=360 | title=Endometriosis | journal=N Engl J Med | pages=268-79 | last1 = Bulun | first1 = SE}}</ref><ref name="bulun 2013">{{cite journal | pmid = 24088094 | doi=10.1056/NEJMra1209993 | volume=369 | title=Uterine fibroids | journal=N Engl J Med | pages=1344-55 | last1 = Bulun | first1 = SE}}</ref><ref name="attar 2006" /><ref name="ono 2013" /><ref name="dyson 2014">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Dyson+MT%2C+Roqueiro+D%2C+Monsivais+D%2C+et+al.+Genome-wide+DNA+methylation+analysis+predicts+an+epigenetic+switch+for+GATA+factor+expression+in+endometriosis.+PLoS+Genet.+2014%3B10(3)%3Ae1004158. Dyson MT, Roqueiro D, Monsivais D, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis.''PLoS Genet''.2014;10(3):e1004158.]</ref>
== Introduction ==


== Biography ==
'''Serdar Bulun, MD''' is a physician scientist, who has made widely acknowledged contributions to the understanding and treatment of the common gynecologic diseases, endometriosis and uterine fibroids.<br />
Bulun was born in [[Malatya]], Turkey in 1959 and moved to Istanbul to attend [[Robert College]] and thereafter [[Istanbul University]] School of Medicine (Çapa Tıp Fakültesi). He completed his residency in obstetrics and gynecology at the [[University at Buffalo]] in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the [[University of Texas Southwestern Medical Center at Dallas]]. Starting from 2003, he established a comprehensive women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related pathology of uterine, breast and ovarian disorders.<ref name="kim 2013">{{cite journal | pmid = 23303565 | doi=10.1210/er.2012-1043 | volume=34 | title=Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer | pmc=3565104 | journal=Endocr Rev | pages=130-62 | last1 = Kim | first1 = JJ | last2 = Kurita | first2 = T | last3 = Bulun | first3 = SE}}</ref> Throughout his career, Dr. Bulun has been awarded over $70 million of research funding in [[endometriosis]], [[uterine fibroids]] and [[breast cancer]]. In his laboratory, he mentored many PhD and MD-PhD students as well as postdoctoral research fellows.<ref name="attar 2006" /><ref name="ono 2013">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Paracrine+activation+of+WNT%2Fbeta-catenin+pathway+in+uterine+leiomyoma+stem+cells+promotes+tumor+growth Ono M, Yin P, Navarro A, et al. Paracrine activation of WNT/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.''Proc Natl Acad Sci USA''.2013;110:17053-8.]</ref><ref name="dyson 2014" /><ref name="kim 2013" /><ref name="bulun 2005">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Regulation+of+aromatase+expression+in+estrogen-responsive+breast+and+uterine+disease%3A+from+bench+to+treatment '''Bulun SE''', Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.''Pharmacol Rev''.2005;57:359-83.]</ref><ref name="shozu 2003" /><ref name="shozu 2003">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Estrogen+excess+associated+with+novel+gain-of-function+mutations+affecting+the+aromatase+gene Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.''N Engl J Med''.2003;348:1855-65.]</ref><ref name="demura 2007">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Regional+rearrangements+in+chromosome+15q21+cause+formation+of+cryptic+promoters+for+the+CYP19+(aromatase)+gene. Demura M, Martin RM, Shozu M, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.''Hum Mol Genet''.2007;16:2529-41.]</ref><ref name="ono 2012">{{cite journal | pmid = 22570742 | doi=10.1371/journal.pone.0036935 | volume=7 | title=Role of stem cells in human uterine leiomyoma growth | pmc=3343011 | journal=PLoS One | pages=e36935 | last1 = Ono | first1 = M | last2 = Qiang | first2 = W | last3 = Serna | first3 = VA | last4 = Yin | first4 = P | last5 = Coon | first5 = | last6 = Navarro | first6 = A | last7 = Monsivais | first7 = D | last8 = Kakinuma | first8 = T | last9 = Dyson | first9 = M | last10 = Druschitz | first10 = S | last11 = Unno | first11 = K | last12 = Kurita | first12 = T | last13 = Bulun | first13 = SE}}</ref><ref name="attia 2000">{{cite journal | pmid = 10946900 | doi=10.1210/jcem.85.8.6739 | volume=85 | title=Progesterone receptor isoform A but not B is expressed in endometriosis | journal=J Clin Endocrinol Metab | pages=2897-902 | last1 = Attia | first1 = GR | last2 = Zeitoun | first2 = K | last3 = Edwards | first3 = D | last4 = Johns | first4 = A | last5 = Carr | first5 = BR | last6 = Bulun | first6 = SE}}</ref><ref name="zhou 2001">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Malignant+breast+epithelial+cells+stimulate+aromatase+expression+via+promoter+II+in+human+adipose+fibroblasts%3A+an+epithelial-stromal+interaction+in+breast+tumors+mediated+by+CCAAT%2Fenhancer+binding+protein+beta. Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.''Cancer Res''.2001;61:2328-34.]</ref>


== Academic career ==
Dr. Bulun serves as the obstetrician and gynecologist-in-chief of the [https://www.nm.org/location/prentice-womens-hospital Prentice Women’s Hospital] of [[Northwestern Memorial Hospital]] in Chicago, IL and Chair of [http://www.feinberg.northwestern.edu/sites/obgyn/ Northwestern University’s Department of Obstetrics and Gynecology], which is one of the largest and most influential women’s health programs in the world. He is one of the rare Turkish-trained physicians, who rose to the rank of a clinical department chair in the United States.<br />
Bulun discovered the epigenetic basis of [[endometriosis]] leading to progesterone resistance in this disease, and introduced [[aromatase inhibitors]] as a novel class of drugs to treat it.<ref name="bulun 2009" /><ref name="attar 2006">[https://www.ncbi.nlm.nih.gov/pubmed/?term=Aromatase+inhibitors%3A+the+next+generation+of+therapeutics+for+endometriosis%3F Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis?''Fertil Steril''.2006;85:1307-18.]</ref><ref name="dyson 2014" /><ref name="attia 2000" /> His team isolated tumor stem cells from [[uterine fibroids]] and targeted these to treat this disease.<ref name="bulun 2013" /><ref name="ono 2013" /><ref name="kim 2013" /><ref name="ono 2012" /> His team discovered the first set of gain-of-function mutations affecting the aromatase gene leading to breast development and estrogen excess in prepubertal humans and contributed to the genetics and systems biology aspects of hormone-responsive disorders of the breast, including cancer.<ref name="bulun 2005" /><ref name="shozu 2003" /><ref name="demura 2007" /><ref name="zhou 2001" />


Bulun is the editor-in-chief of Seminars in Reproductive Medicine.<ref name=thieme>{{cite web|title=Thieme Medical Publishers|url=https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1567816|website=Thieme}}</ref> He has been elected to the [[National Academy of Medicine]] (formerly known as the Institute of Medicine), the [[Association of American Physicians]] and the [[American Society for Clinical Investigation]].<ref name=nam>{{cite web|title=News Center|url=http://news.feinberg.northwestern.edu/2015/10/bulun-elected-to-national-academy-of-medicine/|website=Northwestern Medicine}}</ref><ref name=asci>{{cite web|title=Serdar E. Bulun, M.D.|url=https://www.the-asci.org/controllers/asci/AsciProfileController.php?pid=500282|website=The American Society for Clinical Investigation}}</ref><ref name=aap>{{cite web|title=Member Directory|url=https://aap-online.org/admin/members.php?search=1|website=Association for American Physicians}}</ref> He served as the 2015 president for the [http://www.sri-online.org/ Society for Reproductive Investigation].<ref name=sri>{{cite web|title=SRI Presidents|url=http://www.sri-online.org/about-sri/history-of-sri/sri-presidents|website=Society for Reproductive Investigation}}</ref> He has received the [[National Institutes of Health]]-MERIT award for his work in [[endometriosis]] and the [[American Society of Reproductive Medicine]] Distinguished Researcher Award.<ref name="nih merit award">{{cite web|title=Endometriosis and Retinoids|url=http://grantome.com/grant/NIH/R37-HD038691-12S1|website=Grantome}}</ref><ref name="asrm award">{{cite web|title=ASRM2012: Serdar Bulun honoured as distinguished researcher|url=http://endometriosis.org/news/congress-highlights/asrm2012-serdar-bulun-honoured-as-distinguished-researcher/|website=endometriosis.org}}</ref>
Bulun was born in [[Malatya]], Turkey in 1959 and moved to Istanbul to attend [[Robert College]] and thereafter [[Istanbul University]] School of Medicine (Çapa Tıp Fakültesi). He received his residency training in obstetrics and gynecology at the [[University at Buffalo]] in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the [[University of Texas Southwestern Medical Center at Dallas]]. Starting from 2003, he has set up a world-renowned women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related pathology of uterine, breast and ovarian disorders. Throughout his career, Dr. Bulun has been awarded over $70 million of research funding in [[endometriosis]], [[uterine fibroids]] and [[breast cancer]]. In his laboratory, he mentored many PhD and MD-PhD students and postdoctoral research fellows.


⚫
== Honors ==
Bulun has made a significant global impact on medicine via paradigm-shifting contributions to the genetics and steroid biology of the common gynecologic disorders, [[endometriosis]] and [[uterine fibroids]], which collectively affect more than 200 million women around the world.<ref name="1-bulun 2009">[http://www.ncbi.nlm.nih.gov/pubmed/19144942 '''Bulun SE'''. Endometriosis.''N Engl J Med''.2009;360:268-79].</ref><ref name="2-bulun 2013">[http://www.ncbi.nlm.nih.gov/pubmed/24088094 '''Bulun SE'''. Uterine fibroids.''N Engl J Med''.2013;369:1344-55.]</ref><ref name="3-bulun 2005">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Regulation+of+aromatase+expression+in+estrogen-responsive+breast+and+uterine+disease%3A+from+bench+to+treatment '''Bulun SE''', Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.''Pharmacol Rev''.2005;57:359-83.]</ref> He is internationally acknowledged for discovering the epigenetic basis of [[endometriosis]] and introducing [[aromatase inhibitors]] as a novel class of drugs to effectively treat it.<ref name="4-attar 2006">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Aromatase+inhibitors%3A+the+next+generation+of+therapeutics+for+endometriosis%3F Attar E, '''Bulun SE'''. Aromatase inhibitors: the next generation of therapeutics for endometriosis?''Fertil Steril''.2006;85:1307-18.]</ref> His team for the first time isolated tumor stem cells from uterine fibroids and targeted these to treat this disease.<ref name="5-ono 2013">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Paracrine+activation+of+WNT%2Fbeta-catenin+pathway+in+uterine+leiomyoma+stem+cells+promotes+tumor+growth Ono M, Yin P, Navarro A, et al. Paracrine activation of WNT/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.''Proc Natl Acad Sci USA''.2013;110:17053-8.]</ref> He also contributed significantly to the genetics and systems biology aspects of hormone-responsive disorders of the breast including cancer.<ref name="6-shozu 2003">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Estrogen+excess+associated+with+novel+gain-of-function+mutations+affecting+the+aromatase+gene Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.''N Engl J Med''.2003;348:1855-65.]</ref><ref name="7-demura 2007">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Regional+rearrangements+in+chromosome+15q21+cause+formation+of+cryptic+promoters+for+the+CYP19+(aromatase)+gene. Demura M, Martin RM, Shozu M, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.''Hum Mol Genet''.2007;16:2529-41.]</ref><ref name="8-zhou 2001">[http://www.ncbi.nlm.nih.gov/pubmed/?term=Malignant+breast+epithelial+cells+stimulate+aromatase+expression+via+promoter+II+in+human+adipose+fibroblasts%3A+an+epithelial-stromal+interaction+in+breast+tumors+mediated+by+CCAAT%2Fenhancer+binding+protein+beta. Zhou J, Gurates B, Yang S, Sebastian S, '''Bulun SE'''. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.''Cancer Res''.2001;61:2328-34.]</ref> He has published more than 200 scientific articles including reports in top-ranked journals such as the [[New England Journal of Medicine]], [[Nature Medicine]], and the [[Proceedings of the National Academy of Sciences of the USA]], as well as several specialty journals in reproductive endocrinology and cancer.<br />
⚫
* [[National Academy of Medicine]] (formerly Institute of Medicine, IOM, elected 2015)<ref name=nam />

* John J. Sciarra Professor of Obstetrics and Gynecology, [[Northwestern University]] (2012–present)<ref name=sciarra>{{cite web|title=Faculty Profiles|url=http://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=16755|website=Northwestern Medicine}}</ref>
Bulun has been a widely recognized pioneer of molecular medicine in the field of gynecology. He is the editor-in-chief of [http://www.thieme.com/books-main/obstetrics-and-gynecology/product/2165-seminars-in-reproductive-medicine Seminars in Reproductive Medicine]. He has been elected to the [[National Academy of Medicine]] (formerly known as the Institute of Medicine), the [[Association of American Physicians]] and the [[American Society for Clinical Investigation]], the honor societies for physician-scientists. He served as the 2015 president for the [http://www.sri-online.org/ Society for Reproductive Investigation]. He has received several prestigious awards, including the [[National Institutes of Health]]-MERIT award for his groundbreaking research work in [[endometriosis]] and the [[American Society of Reproductive Medicine]] Distinguished Researcher Award, and has served as a visiting lecturer at leading institutions around the world.<br />
⚫
* [[Association of American Physicians]] (AAP, elected 2012)<ref name=aap />

⚫
* [[American Society for Reproductive Medicine]] (ASRM) Distinguished Researcher Award (2012)<ref name="asrm award" />
== Key Scientific Contributions to Medicine ==
* Introduced aromatase inhibitors as a novel treatment for endometriosis<ref name="4-attar 2006" />
* [[National Institutes of Health]] MERIT (R37) Award HD38691 (2010-2020)<ref name="nih merit award" />
* George H. Gardner Professor of Clinical Gynecology, [[Northwestern University]] (2006-2012)<ref name="george gardner">{{cite web|title=Bulun Appointed Gardner Clinical Professor|url=http://www.northwestern.edu/newscenter/stories/2006/11/bulun_mobile.html|website=Northwestern University News Center}}</ref>
* Discovered the key epigenetic defects in endometriosis leading to progesterone resistance<ref name="1-bulun 2009" />
⚫
* [[American Society for Clinical Investigation]] (ASCI, elected 2003)<ref name=asci />
* Isolated and therapeutically targeted stem cells in uterine fibroids<ref name="2-bulun 2013" />
* Discovered the first set of gain-of-function mutations affecting the aromatase gene leading to breast development and estrogen excess in prepubertal boys and girls<ref name="6-shozu 2003" /><ref name="7-demura 2007" />

⚫
== Key Honors ==
⚫
* [[National Academy of Medicine]] (formerly Institute of Medicine, IOM, elected 2015)
* John J. Sciarra Professor of Obstetrics and Gynecology, Northwestern University (2012–present)
⚫
* [[Association of American Physicians]] (AAP, elected 2012)
⚫
* [[American Society for Reproductive Medicine]] (ASRM) Distinguished Researcher Award (2012)
* [[National Institutes of Health]] MERIT (R37) Award HD38691 (2010-2020)
* George H. Gardner Professor of Clinical Gynecology, [[Northwestern University]] (2006-2012)
⚫
* [[American Society for Clinical Investigation]] (ASCI, elected 2003)

== External links ==
* http://www.feinberg.northwestern.edu/sites/obgyn/research/labs/bulun/index.html
* http://www.feinberg.northwestern.edu/sites/obgyn/


== References ==
== References ==
{{Reflist}}


{{DEFAULTSORT:Bulun, Serdar}}
<!--- Categories --->
[[Category:Year of birth missing (living people)]]

[[Category:Articles created via the Article Wizard]]
[[Category:Living people]]

Revision as of 06:11, 16 December 2017

Serdar Bulun
Born
Malatya, Turkey
Scientific career
Fields
Institutions
Websitehttp://www.feinberg.northwestern.edu/sites/obgyn/research/labs/bulun/index.html

Serdar Bulun, MD is a gynecologist, with a special interest in the common gynecologic diseases, endometriosis and uterine fibroids.[1][2][3][4][5]

Biography

Bulun was born in Malatya, Turkey in 1959 and moved to Istanbul to attend Robert College and thereafter Istanbul University School of Medicine (Çapa Tıp Fakültesi). He completed his residency in obstetrics and gynecology at the University at Buffalo in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the University of Texas Southwestern Medical Center at Dallas. Starting from 2003, he established a comprehensive women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related pathology of uterine, breast and ovarian disorders.[6] Throughout his career, Dr. Bulun has been awarded over $70 million of research funding in endometriosis, uterine fibroids and breast cancer. In his laboratory, he mentored many PhD and MD-PhD students as well as postdoctoral research fellows.[3][4][5][6][7][8][8][9][10][11][12]

Academic career

Bulun discovered the epigenetic basis of endometriosis leading to progesterone resistance in this disease, and introduced aromatase inhibitors as a novel class of drugs to treat it.[1][3][5][11] His team isolated tumor stem cells from uterine fibroids and targeted these to treat this disease.[2][4][6][10] His team discovered the first set of gain-of-function mutations affecting the aromatase gene leading to breast development and estrogen excess in prepubertal humans and contributed to the genetics and systems biology aspects of hormone-responsive disorders of the breast, including cancer.[7][8][9][12]

Bulun is the editor-in-chief of Seminars in Reproductive Medicine.[13] He has been elected to the National Academy of Medicine (formerly known as the Institute of Medicine), the Association of American Physicians and the American Society for Clinical Investigation.[14][15][16] He served as the 2015 president for the Society for Reproductive Investigation.[17] He has received the National Institutes of Health-MERIT award for his work in endometriosis and the American Society of Reproductive Medicine Distinguished Researcher Award.[18][19]

Honors

References

  1. ^ a b Bulun, SE. "Endometriosis". N Engl J Med. 360: 268–79. doi:10.1056/NEJMra0804690. PMID 19144942.
  2. ^ a b Bulun, SE. "Uterine fibroids". N Engl J Med. 369: 1344–55. doi:10.1056/NEJMra1209993. PMID 24088094.
  3. ^ a b c Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis?Fertil Steril.2006;85:1307-18.
  4. ^ a b c Ono M, Yin P, Navarro A, et al. Paracrine activation of WNT/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.Proc Natl Acad Sci USA.2013;110:17053-8.
  5. ^ a b c Dyson MT, Roqueiro D, Monsivais D, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis.PLoS Genet.2014;10(3):e1004158.
  6. ^ a b c Kim, JJ; Kurita, T; Bulun, SE. "Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer". Endocr Rev. 34: 130–62. doi:10.1210/er.2012-1043. PMC 3565104. PMID 23303565.
  7. ^ a b Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.Pharmacol Rev.2005;57:359-83.
  8. ^ a b c Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.N Engl J Med.2003;348:1855-65.
  9. ^ a b Demura M, Martin RM, Shozu M, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.Hum Mol Genet.2007;16:2529-41.
  10. ^ a b Ono, M; Qiang, W; Serna, VA; Yin, P; Coon; Navarro, A; Monsivais, D; Kakinuma, T; Dyson, M; Druschitz, S; Unno, K; Kurita, T; Bulun, SE. "Role of stem cells in human uterine leiomyoma growth". PLoS One. 7: e36935. doi:10.1371/journal.pone.0036935. PMC 3343011. PMID 22570742.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  11. ^ a b Attia, GR; Zeitoun, K; Edwards, D; Johns, A; Carr, BR; Bulun, SE. "Progesterone receptor isoform A but not B is expressed in endometriosis". J Clin Endocrinol Metab. 85: 2897–902. doi:10.1210/jcem.85.8.6739. PMID 10946900.
  12. ^ a b Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.Cancer Res.2001;61:2328-34.
  13. ^ "Thieme Medical Publishers". Thieme.
  14. ^ a b "News Center". Northwestern Medicine.
  15. ^ a b "Serdar E. Bulun, M.D." The American Society for Clinical Investigation.
  16. ^ a b "Member Directory". Association for American Physicians.
  17. ^ "SRI Presidents". Society for Reproductive Investigation.
  18. ^ a b "Endometriosis and Retinoids". Grantome.
  19. ^ a b "ASRM2012: Serdar Bulun honoured as distinguished researcher". endometriosis.org.
  20. ^ "Faculty Profiles". Northwestern Medicine.
  21. ^ "Bulun Appointed Gardner Clinical Professor". Northwestern University News Center.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Serdar_Bulun&oldid=815657934"